2012
DOI: 10.1111/j.1749-4486.2012.02465.x
|View full text |Cite
|
Sign up to set email alerts
|

Introducing the Sophono Alpha 1 abutment free bone conduction hearing system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(9 citation statements)
references
References 5 publications
0
9
0
Order By: Relevance
“…the transcutaneous bone conduction hearing aids Sophono ® (Alpha 1 and 2, Sophono Inc, Boulder, CO, USA) and Xomed Audioant (Xomed Inc., Jacksonville, Fl, USA) use a passive magnetic implant activated by an actuator worn externally. this can overcome the potential local complications of the percutanous BAHS, but still the audiological amplification is lower [12,14].…”
Section: Discussionmentioning
confidence: 99%
“…the transcutaneous bone conduction hearing aids Sophono ® (Alpha 1 and 2, Sophono Inc, Boulder, CO, USA) and Xomed Audioant (Xomed Inc., Jacksonville, Fl, USA) use a passive magnetic implant activated by an actuator worn externally. this can overcome the potential local complications of the percutanous BAHS, but still the audiological amplification is lower [12,14].…”
Section: Discussionmentioning
confidence: 99%
“…A new system is available and marketed as Baha Attract (Cochlear Bone Anchored Solutions, Mölnlycke, Sweden; Briggs et al., 2015 ; Iseri et al., 2015 ). Another, independently developed device (Sophono Alpha; Medtronic, Dublin, Ireland) employs a likewise principle with a flat implantable magnet ( Mulla, Agada, & Reilly, 2012 ; Siegert, 2011 ). Active transcutaneous bone conduction depends on the actuator being implanted into the skull and covered by intact skin.…”
mentioning
confidence: 99%
“…The BCI group in the present study showed an uneven distribution among the four types of devices, and percutaneous systems (pBCI) were more prevalent than transcutaneous systems (tBCI), namely, BAHA Attract [7] and BoneBridge V R [8]. This finding is primarily related to the fact that tBCIs have only recently been made available in clinical practice.…”
Section: Discussionmentioning
confidence: 58%